214 related articles for article (PubMed ID: 23485623)
1. Squamous cell carcinomas of the tongue and oral cavity as secondary malignancies: what factors are implicated?
Muggia F
Oncologist; 2013; 18(3):245-7. PubMed ID: 23485623
[TBL] [Abstract][Full Text] [Related]
2. Squamous cell carcinoma of the oral cavity in a woman with a 9-year history of ovarian cancer: is exposure to pegylated liposomal Doxorubicin a factor?
Randon G; Nicoletto MO; Milite N; Muggia F; Conte P
Oncologist; 2014 Apr; 19(4):429. PubMed ID: 24668330
[TBL] [Abstract][Full Text] [Related]
3. Molecular events in relapsed oral squamous cell carcinoma: Recurrence vs. secondary primary tumor.
Gleber-Netto FO; Braakhuis BJ; Triantafyllou A; Takes RP; Kelner N; Rodrigo JP; Strojan P; Vander Poorten V; Rapidis AD; Rinaldo A; Brakenhoff RH; Ferlito A; Kowalski LP
Oral Oncol; 2015 Aug; 51(8):738-44. PubMed ID: 25987307
[TBL] [Abstract][Full Text] [Related]
4. A role for panendoscopy? Second primary tumour in early stage squamous cell carcinoma of the oral tongue.
Koo K; Harris R; Wiesenfeld D; Iseli TA
J Laryngol Otol; 2015 Jan; 129 Suppl 1():S27-31. PubMed ID: 25656280
[TBL] [Abstract][Full Text] [Related]
5. Of course, early recognition of relapses in squamous cell carcinoma of the tongue is mandatory!
González-García R
J Oral Maxillofac Surg; 2012 Dec; 70(12):2731; author reply 2731. PubMed ID: 23141981
[No Abstract] [Full Text] [Related]
6. Sequential loss of heterozygosity at microsatellite motifs in preinvasive and invasive head and neck squamous carcinoma.
el-Naggar AK; Hurr K; Batsakis JG; Luna MA; Goepfert H; Huff V
Cancer Res; 1995 Jun; 55(12):2656-9. PubMed ID: 7780981
[TBL] [Abstract][Full Text] [Related]
7. Genomic Correlate of Exceptional Erlotinib Response in Head and Neck Squamous Cell Carcinoma.
Van Allen EM; Lui VW; Egloff AM; Goetz EM; Li H; Johnson JT; Duvvuri U; Bauman JE; Stransky N; Zeng Y; Gilbert BR; Pendleton KP; Wang L; Chiosea S; Sougnez C; Wagle N; Zhang F; Du Y; Close D; Johnston PA; McKenna A; Carter SL; Golub TR; Getz G; Mills GB; Garraway LA; Grandis JR
JAMA Oncol; 2015 May; 1(2):238-44. PubMed ID: 26181029
[TBL] [Abstract][Full Text] [Related]
8. Heat shock protein and p53 expression in head and neck squamous cell carcinoma.
Gandour-Edwards R; Trock BJ; Gumerlock P; Donald PJ
Otolaryngol Head Neck Surg; 1998 May; 118(5):610-5. PubMed ID: 9591858
[TBL] [Abstract][Full Text] [Related]
9. Evolution of neck disease in patients with primary squamous cell carcinoma of the oral tongue, floor of mouth, and palatine arch, and clinically positive neck nodes neither fixed nor bilateral.
Northrop M; Fletcher GH; Jesse RH; Lindberg RD
Cancer; 1972 Jan; 29(1):23-30. PubMed ID: 5007385
[No Abstract] [Full Text] [Related]
10. TERT promoter mutation in patients with second primary of tongue squamous cell carcinoma.
Erkul E; Yilmaz I
Oral Oncol; 2021 Mar; 114():105089. PubMed ID: 33189577
[TBL] [Abstract][Full Text] [Related]
11. Oral-specific ablation of Klf4 disrupts epithelial terminal differentiation and increases premalignant lesions and carcinomas upon chemical carcinogenesis.
Paparella ML; Abrigo M; Bal de Kier Joffe E; Raimondi AR
J Oral Pathol Med; 2015 Nov; 44(10):801-9. PubMed ID: 25605610
[TBL] [Abstract][Full Text] [Related]
12. Genomic and epigenetic characterization for the comparison of synchronous bilateral tongue squamous cell carcinomas-A case report.
Ribeiro IP; Barroso L; Marques F; Santos A; Caramelo F; Julião MJ; Melo JB; Carreira IM
Curr Probl Cancer; 2017; 41(6):398-406. PubMed ID: 29056289
[TBL] [Abstract][Full Text] [Related]
13. Expression of Oct3/4 and Nanog in the head and neck squamous carcinoma cells and its clinical implications for delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma.
Habu N; Imanishi Y; Kameyama K; Shimoda M; Tokumaru Y; Sakamoto K; Fujii R; Shigetomi S; Otsuka K; Sato Y; Watanabe Y; Ozawa H; Tomita T; Fujii M; Ogawa K
BMC Cancer; 2015 Oct; 15():730. PubMed ID: 26483189
[TBL] [Abstract][Full Text] [Related]
14. The degree of intratumor mutational heterogeneity varies by primary tumor sub-site.
Ledgerwood LG; Kumar D; Eterovic AK; Wick J; Chen K; Zhao H; Tazi L; Manna P; Kerley S; Joshi R; Wang L; Chiosea SI; Garnett JD; Tsue TT; Chien J; Mills GB; Grandis JR; Thomas SM
Oncotarget; 2016 May; 7(19):27185-98. PubMed ID: 27034009
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-138 and its targets: A therapeutic molecule for oral squamous cell carcinoma.
Selvakumar SC; K Auxzilia P; Dinesh Y; Senthilmurugan M; Sekar D
Oral Oncol; 2022 Jul; 130():105925. PubMed ID: 35606273
[No Abstract] [Full Text] [Related]
16. Angiogenesis-related prognosis in patients with oral squamous cell carcinoma-role of the VEGF +936 C/T polymorphism.
Kämmerer PW; Al-Nawas B; Kalkan S; Liese J; Fruth K; Frerich B; Brieger J
J Oral Pathol Med; 2015 Jul; 44(6):429-36. PubMed ID: 25213013
[TBL] [Abstract][Full Text] [Related]
17. RIOK2 Contributes to Cell Growth and Protein Synthesis in Human Oral Squamous Cell Carcinoma.
Matsuzaki Y; Naito Y; Miura N; Mori T; Watabe Y; Yoshimoto S; Shibahara T; Takano M; Honda K
Curr Oncol; 2022 Dec; 30(1):381-391. PubMed ID: 36661680
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol suppresses TPA-induced matrix metalloproteinase-9 expression through the inhibition of MAPK pathways in oral cancer cells.
Lin FY; Hsieh YH; Yang SF; Chen CT; Tang CH; Chou MY; Chuang YT; Lin CW; Chen MK
J Oral Pathol Med; 2015 Oct; 44(9):699-706. PubMed ID: 25401496
[TBL] [Abstract][Full Text] [Related]
19. Tumor DNA content as a prognostic indicator in squamous cell carcinoma of the oral cavity and tongue base.
Rubio Bueno P; Naval Gias L; García Delgado R; Domingo Cebollada J; Díaz González FJ
Head Neck; 1998 May; 20(3):232-9. PubMed ID: 9570629
[TBL] [Abstract][Full Text] [Related]
20. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
